New Ways to Treat Acute Myeloid Leukemia
The Memorial Sloan Kettering Cancer Center SPORE in Leukemia
['FUNDING_OTHER'] · SLOAN-KETTERING INST CAN RESEARCH · NIH-11124231
This project aims to find new, effective treatments for acute myeloid leukemia, especially for patients whose current therapies are not working well.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | SLOAN-KETTERING INST CAN RESEARCH (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-11124231 on ClinicalTrials.gov |
What this research studies
Acute myeloid leukemia (AML) often returns after treatment, and many adults face low survival rates, highlighting a critical need for better options. This initiative brings together experts to create new targeted therapies and immune-based treatments for different types of AML. We are focusing on understanding the genetic and molecular causes of AML and developing treatments that specifically target these issues. Our goal is to identify effective new therapies and understand why they work, or why they might not, for patients with AML.
Who could benefit from this research
Good fit: Patients with acute myeloid leukemia, particularly those with specific molecular subtypes or who have relapsed after initial treatment, could potentially benefit from future therapies developed through this research.
Not a fit: Patients without acute myeloid leukemia or those whose specific leukemia type is not targeted by these particular approaches may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new, more effective treatments for acute myeloid leukemia, improving survival and quality of life for patients.
How similar studies have performed: This research builds upon recent advances in AML treatment while focusing on developing novel, targeted approaches for specific leukemia subtypes that currently lack effective options.
Where this research is happening
NEW YORK, UNITED STATES
- SLOAN-KETTERING INST CAN RESEARCH — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ABDEL-WAHAB, OMAR — SLOAN-KETTERING INST CAN RESEARCH
- Study coordinator: ABDEL-WAHAB, OMAR
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.